Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Arsanis- Inc. (ASNS)

18.01 -0.93 (-4.91%)

06-25 15:35

Open:

18.74

Pre. Close:

18.94

High:

18.74

Low:

17.65

Volume:

31,524

Market Cap:

257M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.999 - 19.093

19.093 - 19.188

Low:

15.533 - 15.616

15.616 - 15.699

Close:

18.783 - 18.938

18.938 - 19.095

Technical analysis  (as of: 2018-06-25 3:25:37 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 22.67     One year: 26.48

Support:

Support1: 16.63    Support2: 14.91

Resistance:

Resistance1: 19.41    Resistance2: 22.67

Pivot:

17.22

Moving Averages:

MA(5): 17.41     MA(20): 17.17

MA(100): 18.22     MA(250):

MACD:

MACD(12,26): -0.24     Signal(12,26,9): -0.43

%K %D:

%K(14,3): 61.02     %D(3): 46.85

RSI:

RSI(14): 51.30

52-Week:

High: 28.694  Low: 10.4  Change(%): -28.9

Average Vol(K):

3-Month: 3276  10-Days 5112

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ASNS has closed below upper band by 30.0%. Bollinger Bands are 54.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ASNS's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-12T09:16:17-04:00
Stocks To Watch: A Fed Head Talks Crypto

2018-05-10T07:28:39-04:00
Arsanis beats by $0.30

2018-05-10T07:00:00-04:00
Arsanis Reports Business Highlights and Financial Results for First Quarter 2018

2018-04-30T12:49:42-04:00
Midday Gainers / Losers (04/30/2018)

2018-04-20T10:17:00-04:00
Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

2018-04-17T08:00:00-04:00
Arsanis to Present at the 28th European Congress of Clinical Microbiology and Infectious Diseases

2018-04-04T08:00:00-04:00
Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies

2018-03-30T13:44:00-04:00
Alphabet's bets on health tech are paying off as portfolio companies go public

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

14.29

Shares Float (M)

13.63

% Held by Insiders

4.70

% Held by Institutions

52.20

Shares Short (K)

181

Shares Short Prior Month (K)

170

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

-4.163

Book Value (p.s.)

4.880

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-56.6

Return on Equity (ttm)

-80.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.54

Levered Free Cash Flow (M)

-26.67

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

3.65

P/S

P/CF

-6.96

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.